KAS
UTHR icon

Kemnay Advisory Services’s United Therapeutics UTHR Stock Holding History

Kemnay Advisory Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.75K Buy
18
+1
+6% +$563 ﹤0.01% 1053
2026
Q1 		$10.1K Buy
+17
New +$8.47K ﹤0.01% 996
2020
Q3 		– Sell
-4,441
Closed -$537K – 102
2020
Q2 		$537K Buy
+4,441
New +$500K 0.08% 60

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Kemnay Advisory Services's UTHR Position: Q2 2026 in Review

Kemnay Advisory Services increased its United Therapeutics (UTHR) stake by 5.9% in Q2 2026, buying an estimated $563 and bringing the position to 18 shares worth $9.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1053.

Kemnay Advisory Services first reported a position in UTHR in Q2 2020 and has held it in 3 quarters since. The position peaked at $537K in Q2 2020. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Kemnay Advisory Services held 18 shares of United Therapeutics worth $9.75K as of Q2 2026.
  • Kemnay Advisory Services bought 1 United Therapeutics share in Q2 2026, an estimated $563.
  • United Therapeutics made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #1053 holding.
  • Kemnay Advisory Services first reported a position in United Therapeutics in Q2 2020 and has held it in 3 quarters since.
  • Kemnay Advisory Services's United Therapeutics position peaked at $537K in Q2 2020.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.